TickerFacts.

Advanced Biomed Inc. (ADVB): R&D Expense

Annual figures by period end, from SEC filings.

$909.8K
Year ended 2025-06-30
2024-06-30: $880.2K2025-06-30: $909.8K$909.8K
2024-06-30 R&D Expense (USD) 2025-06-30
Period endedR&D ExpenseChange YoYSource filing
2025-06-30$909.8K+3.4%2025-10-08, From 2024-07-01
2024-06-30$880.2Kn/a2025-10-08, From 2023-07-01

R&D Expense at similar companies

Companies with the same SEC industry code (Services-Medical Laboratories), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedR&D ExpenseChange YoY
Advanced Biomed Inc. (ADVB)2025-06-30$909.8K+3.4%
Renalytix plc (RNLXY)2024-06-30$9.29M-35.0%
BioNexus Gene Lab Corp (BGLC)2025-12-31$50.7K+6.6%
Aclarion, Inc. (ACON)2025-12-31$1.03M+16.3%
YD Bio Ltd (YDES)2025-12-31$1.60M+226.1%
Exagen Inc. (XGN)2025-12-31$6.25M+16.4%
Biodesix Inc (BDSX)2025-12-31$12.00M+25.5%
Sera Prognostics, Inc. (SERA)2025-12-31$13.17M-10.6%
Ludwig Enterprises, Inc. (LUDG)2025-12-31$231.6K+39.8%

Compare ADVB, RNLXY, BGLC, ACON side by side · Screen every company in Services-Medical Laboratories ↗